Psilocybin Mushrooms Becoming One of the Hottest Investment Stories of 2020 January 07, 2020 - Baystreet.ca The psilocybin mushroom story is in the early stages of a multi-year boom. In fact, we’re already seeing a groundswell of interest, as mushrooms become a promising candidate for anxiety and depression because it “appears to disrupt the sorts of engrained brain activity patterns that are the hallmark of those diseases,” says Business Insider. That news holds sizable promise for companies, such as The Yield Growth Corp. (CSE:BOSS)(OTC:BOSQF). Other studies are looking at psilocybin mushroom’s effect on anxiety, PTSD, and alcoholism. For example, researchers at New York University found psilocybin mushrooms caused a “rapid and sustained” reduction in anxiety and depression in patients with cancer, as reported by the Financial Post. “Theoretically, psilocybin helps "loosen" the deeply-rooted patterns of thinking and behavior behind many of these mental disorders, according to King's College London, as highlighted by CNN. “It could ‘relax’ the parts of our brain that control these behaviors, thus allowing old patterns to change or fade. Patients who have received psilocybin have described coming down from the high with "new insights" and changed perspectives on their difficulties.” In short, the psychedelic story is just getting underway – and it’s already creating sizable opportunity for companies such as The Yield Growth Corp. (CSE:BOSS)(OTC:BOSQF), Charlotte’s Web Holdings Inc. (OTC:CWBHF) (CN:CWEB), The Supreme Cannabis Company Inc. (TSX:FIRE) (OTC:SPRWF), Delta 9 Cannabis Inc. (TSX:DN)(OTC:VRNDF), and The Green Organic Dutchman (TSX:TGOD)(OTC:TGODF). The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. just announced its subsidiary Flourish Mushroom Labs Inc. entered into a binding letter of intent with Acres Agricultural Canada Corp. to jointly form a company in Saint Vincent and the Grenadines, Acres Flourish Labs (SVG) Ltd., to build a laboratory for the cultivation of psilocybin mushrooms and for research and development into compounds and therapeutic use of psychedelic mushrooms. The agreement contemplates that the proposed research and development of psilocybin for therapeutic use is within the purview of St. Vincent’s Plant Breeders’ Protection Bill, 2019and the wider establishment of a viable and sustainable modern medicinal industry in St. Vincent and the Grenadines. The proposing parties are aware of and keenly interested in the conducive climatic conditions as exist in Saint Vincent for the controlled cultivation of psilocybin mushrooms, coupled with the existing offshore medical academic programs which can create an ideal environment for the advancement of the necessary scientific studies in Saint Vincent. "Acres Agricultural is very pleased to announce this collaboration with Yield Growth Corp. and Flourish Mushroom Labs Inc,” says Patrick Power, CEO of Acres, “Through AF Labs we aim to further the global research and associated medicinal use of psilocybin, while contributing to the development of a new medical frontier for the country of St. Vincent and the Grenadines." “We are very excited to be the first publicly traded company to announce a legal path to cultivate and research psychedelic mushrooms,” says Yield Growth and Flourish CEO Penny White, “There is a renaissance of psychedelic medicine for which investor interest could go viral at any time. We are planning to enter this space with first mover advantage to deliver value to our shareholders.” Other related developments from around the markets include: The Supreme Cannabis Company Inc. (TSX:FIRE)(OTC:SPRWF) announced its Board of Directors has named Colin Moore, Director of the Company and former President of Starbucks Coffee Canada, as Interim President and Chief Executive Officer, effective immediately. Mr. Moore succeeds Navdeep Dhaliwal, who has departed the Company. The Company is in the process of engaging a leading, nationally recognized search firm to identify and evaluate a new CEO to lead Supreme Cannabis in its next phase of profitable, long-term growth. “Today, with Supreme Cannabis firmly established as one of the world’s fastest-growing, premium plant driven-lifestyle companies and our industry entering its second phase, the Board determined that the Company would benefit from leadership with the skills and experience to accelerate our growth and transformation into a leading cannabis CPG company,” Supreme Cannabis Board Chairman, Michael La Brier said. “We are fortunate to have Colin Moore stepping up to serve as our Interim CEO and lead our efforts to drive long-term, profitable growth and shareholder value during this transitional period.” Delta 9 Cannabis Inc. (TSX:DN)(OTC:VRNDF) announced that on December 4, 2019 it received an updated processing license from Health Canada. The license authorizes Delta 9 to sell cannabis extracts, cannabis topicals, and edible cannabis products as defined under the Cannabis Regulations (Canada). This development, following the Company’s submission to Health Canada of new product notifications for nine (9) new derivative cannabis products on November 5, 2019, means the Company will be authorized to begin sales of cannabis extracts on January 5, 2020 “This is an exciting milestone for us,” said John Arbuthnot, CEO of Delta 9, “Our team has worked tirelessly toward our initial rollout of vaporizable oil cartridges, disposable vape oil pens, and dried cannabis extracts. We plan to begin shipments of these products early in the new year.” The Green Organic Dutchman (TSX:TGOD)(OTC:TGODF) just announced it has closed the previously announced senior secured first lien credit facility of up to $42.7 million with Maynbridge Capital Inc. The Facility consists of a committed $27.7 million senior secured term loan with an 18-month term, and an additional uncommitted $15.0 million senior secured term loan to be made available upon the Lender’s credit approval and the achievement of certain operating and financial milestones which the Company expects to obtain and achieve not earlier than the end of the third quarter of 2020. Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of www.MarijuanaStox.com) and The Yield Growth Corp., Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer. Contact Information: 2818047972 ty@MarijuanaStox.com
Psilocybin Mushrooms Becoming One of the Hottest Investment Stories of 2020 January 07, 2020 - Baystreet.ca The psilocybin mushroom story is in the early stages of a multi-year boom. In fact, we’re already seeing a groundswell of interest, as mushrooms become a promising candidate for anxiety and depression because it “appears to disrupt the sorts of engrained brain activity patterns that are the hallmark of those diseases,” says Business Insider. That news holds sizable promise for companies, such as The Yield Growth Corp. (CSE:BOSS)(OTC:BOSQF). Other studies are looking at psilocybin mushroom’s effect on anxiety, PTSD, and alcoholism. For example, researchers at New York University found psilocybin mushrooms caused a “rapid and sustained” reduction in anxiety and depression in patients with cancer, as reported by the Financial Post. “Theoretically, psilocybin helps "loosen" the deeply-rooted patterns of thinking and behavior behind many of these mental disorders, according to King's College London, as highlighted by CNN. “It could ‘relax’ the parts of our brain that control these behaviors, thus allowing old patterns to change or fade. Patients who have received psilocybin have described coming down from the high with "new insights" and changed perspectives on their difficulties.” In short, the psychedelic story is just getting underway – and it’s already creating sizable opportunity for companies such as The Yield Growth Corp. (CSE:BOSS)(OTC:BOSQF), Charlotte’s Web Holdings Inc. (OTC:CWBHF) (CN:CWEB), The Supreme Cannabis Company Inc. (TSX:FIRE) (OTC:SPRWF), Delta 9 Cannabis Inc. (TSX:DN)(OTC:VRNDF), and The Green Organic Dutchman (TSX:TGOD)(OTC:TGODF). The Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) BREAKING NEWS: The Yield Growth Corp. just announced its subsidiary Flourish Mushroom Labs Inc. entered into a binding letter of intent with Acres Agricultural Canada Corp. to jointly form a company in Saint Vincent and the Grenadines, Acres Flourish Labs (SVG) Ltd., to build a laboratory for the cultivation of psilocybin mushrooms and for research and development into compounds and therapeutic use of psychedelic mushrooms. The agreement contemplates that the proposed research and development of psilocybin for therapeutic use is within the purview of St. Vincent’s Plant Breeders’ Protection Bill, 2019and the wider establishment of a viable and sustainable modern medicinal industry in St. Vincent and the Grenadines. The proposing parties are aware of and keenly interested in the conducive climatic conditions as exist in Saint Vincent for the controlled cultivation of psilocybin mushrooms, coupled with the existing offshore medical academic programs which can create an ideal environment for the advancement of the necessary scientific studies in Saint Vincent. "Acres Agricultural is very pleased to announce this collaboration with Yield Growth Corp. and Flourish Mushroom Labs Inc,” says Patrick Power, CEO of Acres, “Through AF Labs we aim to further the global research and associated medicinal use of psilocybin, while contributing to the development of a new medical frontier for the country of St. Vincent and the Grenadines." “We are very excited to be the first publicly traded company to announce a legal path to cultivate and research psychedelic mushrooms,” says Yield Growth and Flourish CEO Penny White, “There is a renaissance of psychedelic medicine for which investor interest could go viral at any time. We are planning to enter this space with first mover advantage to deliver value to our shareholders.” Other related developments from around the markets include: The Supreme Cannabis Company Inc. (TSX:FIRE)(OTC:SPRWF) announced its Board of Directors has named Colin Moore, Director of the Company and former President of Starbucks Coffee Canada, as Interim President and Chief Executive Officer, effective immediately. Mr. Moore succeeds Navdeep Dhaliwal, who has departed the Company. The Company is in the process of engaging a leading, nationally recognized search firm to identify and evaluate a new CEO to lead Supreme Cannabis in its next phase of profitable, long-term growth. “Today, with Supreme Cannabis firmly established as one of the world’s fastest-growing, premium plant driven-lifestyle companies and our industry entering its second phase, the Board determined that the Company would benefit from leadership with the skills and experience to accelerate our growth and transformation into a leading cannabis CPG company,” Supreme Cannabis Board Chairman, Michael La Brier said. “We are fortunate to have Colin Moore stepping up to serve as our Interim CEO and lead our efforts to drive long-term, profitable growth and shareholder value during this transitional period.” Delta 9 Cannabis Inc. (TSX:DN)(OTC:VRNDF) announced that on December 4, 2019 it received an updated processing license from Health Canada. The license authorizes Delta 9 to sell cannabis extracts, cannabis topicals, and edible cannabis products as defined under the Cannabis Regulations (Canada). This development, following the Company’s submission to Health Canada of new product notifications for nine (9) new derivative cannabis products on November 5, 2019, means the Company will be authorized to begin sales of cannabis extracts on January 5, 2020 “This is an exciting milestone for us,” said John Arbuthnot, CEO of Delta 9, “Our team has worked tirelessly toward our initial rollout of vaporizable oil cartridges, disposable vape oil pens, and dried cannabis extracts. We plan to begin shipments of these products early in the new year.” The Green Organic Dutchman (TSX:TGOD)(OTC:TGODF) just announced it has closed the previously announced senior secured first lien credit facility of up to $42.7 million with Maynbridge Capital Inc. The Facility consists of a committed $27.7 million senior secured term loan with an 18-month term, and an additional uncommitted $15.0 million senior secured term loan to be made available upon the Lender’s credit approval and the achievement of certain operating and financial milestones which the Company expects to obtain and achieve not earlier than the end of the third quarter of 2020. Legal Disclaimer / Except for the historical information presented herein, matters discussed in this article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Winning Media which has a partnership with www.MarijuanaStox.com is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. For making specific investment decisions, readers should seek their own advice. Winning Media, which has a partnership with www.MarijuanaStox.com, is only compensated for its services in the form of cash-based compensation. Pursuant to an agreement between Winning Media (partners of www.MarijuanaStox.com) and The Yield Growth Corp., Winning Media has been paid three thousand five hundred dollars for advertising and marketing services for The Yield Growth Corp. We own ZERO shares of The Yield Growth Corp. Please click here for full disclaimer. Contact Information: 2818047972 ty@MarijuanaStox.com